150 related articles for article (PubMed ID: 11997288)
1. Adenylyl cyclase increases survival in cardiomyopathy.
Roth DM; Bayat H; Drumm JD; Gao MH; Swaney JS; Ander A; Hammond HK
Circulation; 2002 Apr; 105(16):1989-94. PubMed ID: 11997288
[TBL] [Abstract][Full Text] [Related]
2. Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy.
Roth DM; Gao MH; Lai NC; Drumm J; Dalton N; Zhou JY; Zhu J; Entrikin D; Hammond HK
Circulation; 1999 Jun; 99(24):3099-102. PubMed ID: 10377071
[TBL] [Abstract][Full Text] [Related]
3. Controlled expression of cardiac-directed adenylylcyclase type VI provides increased contractile function.
Gao MH; Bayat H; Roth DM; Yao Zhou J; Drumm J; Burhan J; Hammond HK
Cardiovasc Res; 2002 Nov; 56(2):197-204. PubMed ID: 12393090
[TBL] [Abstract][Full Text] [Related]
4. Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction.
Takahashi T; Tang T; Lai NC; Roth DM; Rebolledo B; Saito M; Lew WY; Clopton P; Hammond HK
Circulation; 2006 Aug; 114(5):388-96. PubMed ID: 16864723
[TBL] [Abstract][Full Text] [Related]
5. Disruption of adenylyl cyclase type V does not rescue the phenotype of cardiac-specific overexpression of Galphaq protein-induced cardiomyopathy.
Timofeyev V; Porter CA; Tuteja D; Qiu H; Li N; Tang T; Singapuri A; Han PL; Lopez JE; Hammond HK; Chiamvimonvat N
Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1459-67. PubMed ID: 20709863
[TBL] [Abstract][Full Text] [Related]
6. Cardiac-directed expression of adenylyl cyclase reverses electrical remodeling in cardiomyopathy.
Timofeyev V; He Y; Tuteja D; Zhang Q; Roth DM; Hammond HK; Chiamvimonvat N
J Mol Cell Cardiol; 2006 Jul; 41(1):170-81. PubMed ID: 16750219
[TBL] [Abstract][Full Text] [Related]
7. Adenylyl cyclase type VI gene transfer reduces phospholamban expression in cardiac myocytes via activating transcription factor 3.
Gao MH; Tang T; Guo T; Sun SQ; Feramisco JR; Hammond HK
J Biol Chem; 2004 Sep; 279(37):38797-802. PubMed ID: 15231818
[TBL] [Abstract][Full Text] [Related]
8. Adenylyl cyclase: a new target for heart failure therapeutics.
Feldman AM
Circulation; 2002 Apr; 105(16):1876-8. PubMed ID: 11997269
[No Abstract] [Full Text] [Related]
9. Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice.
Lai NC; Tang T; Gao MH; Saito M; Takahashi T; Roth DM; Hammond HK
J Am Coll Cardiol; 2008 Apr; 51(15):1490-7. PubMed ID: 18402905
[TBL] [Abstract][Full Text] [Related]
10. Transgenic replacement of type V adenylyl cyclase identifies a critical mechanism of beta-adrenergic receptor dysfunction in the G alpha q overexpressing mouse.
Tepe NM; Liggett SB
FEBS Lett; 1999 Sep; 458(2):236-40. PubMed ID: 10481072
[TBL] [Abstract][Full Text] [Related]
11. Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure.
Lai NC; Roth DM; Gao MH; Tang T; Dalton N; Lai YY; Spellman M; Clopton P; Hammond HK
Circulation; 2004 Jul; 110(3):330-6. PubMed ID: 15249510
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice.
Hayakawa Y; Chandra M; Miao W; Shirani J; Brown JH; Dorn GW; Armstrong RC; Kitsis RN
Circulation; 2003 Dec; 108(24):3036-41. PubMed ID: 14638549
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation.
Westenbrink BD; Ling H; Divakaruni AS; Gray CB; Zambon AC; Dalton ND; Peterson KL; Gu Y; Matkovich SJ; Murphy AN; Miyamoto S; Dorn GW; Heller Brown J
Circ Res; 2015 Feb; 116(5):e28-39. PubMed ID: 25605649
[TBL] [Abstract][Full Text] [Related]
14. Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse.
Asai K; Yang GP; Geng YJ; Takagi G; Bishop S; Ishikawa Y; Shannon RP; Wagner TE; Vatner DE; Homcy CJ; Vatner SF
J Clin Invest; 1999 Sep; 104(5):551-8. PubMed ID: 10487769
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of adenylylcyclase type VI proportionately increases beta-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes.
Gao M; Ping P; Post S; Insel PA; Tang R; Hammond HK
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1038-43. PubMed ID: 9448281
[TBL] [Abstract][Full Text] [Related]
16. Decreased type VI adenylyl cyclase mRNA concentration and Mg(2+)-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn(2+)-dependent adenylyl cyclase activities in the left ventricle of rats with myocardial infarction and longstanding heart failure.
Espinasse I; Iourgenko V; Richer C; Heimburger M; Defer N; Bourin MC; Samson F; Pussard E; Giudicelli JF; Michel JB; Hanoune J; Mercadier JJ
Cardiovasc Res; 1999 Apr; 42(1):87-98. PubMed ID: 10434999
[TBL] [Abstract][Full Text] [Related]
17. Adenylyl cyclase type V deletion increases basal left ventricular function and reduces left ventricular contractile responsiveness to beta-adrenergic stimulation.
Tang T; Lai NC; Roth DM; Drumm J; Guo T; Lee KW; Han PL; Dalton N; Gao MH
Basic Res Cardiol; 2006 Mar; 101(2):117-26. PubMed ID: 16283593
[TBL] [Abstract][Full Text] [Related]
18. Cardiac-directed expression of adenylyl cyclase VI facilitates atrioventricular nodal conduction.
Sastry A; Arnold E; Gurji H; Iwasa A; Bui H; Hassankhani A; Patel HH; Feramisco JR; Roth DM; Lai NC; Hammond HK; Narayan SM
J Am Coll Cardiol; 2006 Aug; 48(3):559-65. PubMed ID: 16875984
[TBL] [Abstract][Full Text] [Related]
19. Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling.
Tepe NM; Lorenz JN; Yatani A; Dash R; Kranias EG; Dorn GW; Liggett SB
Biochemistry; 1999 Dec; 38(50):16706-13. PubMed ID: 10600134
[TBL] [Abstract][Full Text] [Related]
20. Expression of adenylyl cyclase and G-protein beta subunit in end-stage human heart failure.
Holmer SR; Eschenhagen T; Nose M; Riegger GA
J Card Fail; 1996 Dec; 2(4):279-83. PubMed ID: 8989642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
